Computationally Motivated Discovery of Biogenic Compounds with Potent CDK9 Inhibition and In Vitro Effects against Glioblastoma
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.5c00557 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Zahra R Khan und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy & Biomedical Sciences, University of Lancashire, Preston PR1 2HE, U.K. Hauptthemen laut MEDLINE: Glioblastoma, Cyclin-Dependent Kinase 9, Brain Neoplasms, Protein Kinase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Sydney Driscoll Neuroscience Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy & Biomedical Sciences, University of Lancashire, Preston PR1 2HE, U.K.
- Department of Education, Royal College of Physicians, Liverpool L7 3FA, U.K.
- Biomedical Evidence-Based Transdisciplinary (BEST) Health Research Institute, University of Lancashire, Preston PR1 2HE, U.K.
ORCID-Profile: Joseph M Hayes
Förderung
- Sydney Driscoll Neuroscience Foundation
Zitieren
APA
Khan, Z. R., Welsby, P. J., Stasik, I., & Hayes, J. M. (2025). Computationally Motivated Discovery of Biogenic Compounds with Potent CDK9 Inhibition and In Vitro Effects against Glioblastoma. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00557
Vancouver
Khan ZR, Welsby PJ, Stasik I, Hayes JM. Computationally Motivated Discovery of Biogenic Compounds with Potent CDK9 Inhibition and In Vitro Effects against Glioblastoma. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00557
BibTeX
@article{Khan2025,
author = {Khan, Zahra R and Welsby, Philip J and Stasik, Izabela and Hayes, Joseph M},
title = {Computationally Motivated Discovery of Biogenic Compounds with Potent CDK9 Inhibition and In Vitro Effects against Glioblastoma},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.5c00557}
}
EUVIMED